Bristol Haematology and Oncology Centre
Bristol, United Kingdom
Hospital department in Bristol, England
22 Horfield Rd, Bristol BS2 8ED
About Bristol Haematology and Oncology Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
European Organisation for Research and Treatment of Cancer - EORTC
18
Hoffmann-La Roche
17
Medical Research Council
11
Institute of Cancer Research, United Kingdom
9
University College, London
9
Cancer Research UK
5
Janssen Research & Development, LLC
5
The Christie NHS Foundation Trust
4
University of Leeds
4
Celgene
3
Lisette Nixon
3
Clinical Trials at Bristol Haematology and Oncology Centre
During the past decade, Bristol Haematology and Oncology Centre conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 27 clinical trials were completed, i.e. on
average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma
1996-04-01
Unknown status
1,000
Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer
1996-12-01
2005-11-01
Completed
704
Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease
1997-01-01
Unknown status
400
Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer
1998-04-01
2005-07-01
Completed
800
Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer
1997-12-01
2009-03-01
Completed
45
Radiation Therapy in Treating Patients With Prostate Cancer
1998-01-01
2004-08-01
Completed
800
High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
1993-01-01
Unknown status
500
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bristol Haematology and Oncology Centre" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 18 trials, followed by "Hoffmann-La Roche" with 17 trials
sponsored, "Medical Research Council" with 11 trials sponsored, "Institute of Cancer Research, United Kingdom" with 9 trials sponsored and "University College, London"
with 9 trials sponsored. Other sponsors include 93 different institutions and
companies that sponsored additional 68 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bristol Haematology and Oncology Centre"
#1 collaborator was "Cancer Research UK" with 19 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Institute of Cancer Research, United Kingdom" with 4 trials as a collaborator, "Celgene" with 3 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 71 different institutions and companies that were
collaborators in the rest 66 trials.
Clinical Trials Conditions at Bristol Haematology and Oncology Centre
According to Clinical.Site data, the most researched conditions in "Bristol Haematology and Oncology Centre" are
"Prostate Cancer" (10 trials), "Breast Cancer" (9 trials), "Colorectal Cancer" (9 trials), "Lymphoma" (6 trials) and "Bladder Cancer" (5 trials). Many other conditions were trialed in "Bristol Haematology and Oncology Centre" in a lesser frequency.
Clinical Trials Intervention Types at Bristol Haematology and Oncology Centre
Most popular intervention types in "Bristol Haematology and Oncology Centre" are "Drug" (127 trials), "Radiation" (31 trials), "Procedure" (30 trials), "Biological" (25 trials) and "Other" (22 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (22 trials), "radiation therapy" (16 trials), "adjuvant therapy" (12 trials), "capecitabine" (9 trials) and "cyclophosphamide" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Bristol Haematology and Oncology Centre
The vast majority of trials in "Bristol Haematology and Oncology Centre" are
133 trials for "All" genders, 16 trials for "Male" genders and 13 trials for "Female" genders.
Clinical Trials Status at Bristol Haematology and Oncology Centre
Currently, there are NaN active trials in "Bristol Haematology and Oncology Centre".
1 are not yet recruiting,
25 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 85 completed trials in Bristol Haematology and Oncology Centre,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Bristol Haematology and Oncology Centre, 8 "Phase 1"
clinical trials were conducted, 54 "Phase 2" clinical
trials and 91 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 11 trials that are defined as “Not Applicable".